Alibaba
BABA
Broadcom
AVGO
Disney
DIS
Meta Platforms
META
Advanced Micro Devices
AMD
US Stock MarketDetailed Quotes
RVMD Revolution Medicines
- 41.870
- +0.730+1.77%
Trading Jan 24 12:15 ET
7.74BMarket Cap-11.44P/E (TTM)
42.040High40.065Low658.54KVolume41.040Open41.140Pre Close26.98MTurnover0.39%Turnover RatioLossP/E (Static)184.80MShares62.40052wk High4.94P/B7.08BFloat Cap26.95052wk Low--Dividend TTM169.00MShs Float62.400Historical High--Div YieldTTM4.80%Amplitude14.080Historical Low40.962Avg Price1Lot Size
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Revolution Medicines Stock Forum
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte (INCY.US)$
$BeiGene (BGNE.US)$
$ACADIA Pharmaceuticals (ACAD.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Revolution Medicines (RVMD.US)$
$Kymera Therapeutics (KYMR.US)$
$AbCellera Biologics (ABCL.US)$
$Bicycle Therapeutics (BCYC.US)$
$Edgewise Therapeutics (EWTX.US)$
$Immunocore (IMCR.US)$
$Kodiak Sciences (KOD.US)$
$Roivant Sciences (ROIV.US)$
...
RVMD gained 10.6% to close at $36.50 on word of the experimental drug, which the company disclosed in the publication Cancer Discovery.
Revolution disclosed news of the drug on Tuesday shortly before the market closed, sending shares up 3.4% that da...
Someone just sold 25000 shares. How good they are in timing.
👀👀 breaking out
William Blair analyst Jeff Schmitt downgraded $Focus Financial Partners (FOCS.US)$ to Market Perform from Outperform after the company reached an agreement to be acquired by Clayton, Dubilier & Rice and Stone Point Capital in an all-cash transaction valued at $53 in cash per share.
Credit Suisse Upgrades Celsius Holdings to Outperform, Raises Price Target to $...
No comment yet